Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Hemosiderosis

• Analysis of the Effect of Iron Supplements on Iron Deficiency Anemia in Pregnancy
• Safety Study of Crushed Deferasirox Film Coated Tablets in Pediatric Patients With Transfusional Hemosiderosis
• Treatment of Iron Overload Requiring Chelation Therapy
• Study Of Efficacy,Safety of Combined Deferasirox and Deferiprone Versus Combined Deferiprone and Desferal In Conditions of Iron Overload
• Observation of Patients With Transfusional Hemosiderosis Treatment With Deferasirox
• Clinical Importance of Treating Iron Overload in Sickle Cell Disease
• Palatability and Tolerability of Deferasirox Taken With Meals, With Different Liquids or Crushed and Added to Food
• Efficacy and Safety of Deferasirox in Patients With Chronic Anemia and Transfusional Hemosiderosis
• Evaluating Use of Deferasirox as Compared to Deferoxamine in Treating Cardiac Iron Overload
• Safety, Tolerability, and Efficacy of Deferasirox in MDS
• Extension Study of Iron Chelation Therapy With Deferasirox in β-thalassemia and Rare Chronic Anemia Patients
• Extension Study of the Efficacy and Safety of Deferasirox Treatment in Beta-thalassemia Patients With Transfusional Hemosiderosis (Study Amended to 2-year Duration)
• A Study of Long-term Treatment With Deferasirox in Patients With Beta-thalassemia and Transfusional Hemosiderosis
• Efficacy Study in Removing Excess Iron From the Heart
• Safety of ICL670 vs. Deferoxamine in Sickle Cell Disease Patients With Iron Overload Due to Blood Transfusions
• Safety & Efficacy of ICL670 vs. Deferoxamine in Beta-thalassemia Patients With Iron Overload Due to Blood Transfusions